Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Microscopic hematuria, Focal segmental glomerulosclerosis, and Steroid-resistant nephrotic syndrome; and common findings: Stage 5 chronic kidney disease. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 5 | Stage 5 chronic kidney disease, Microscopic hematuria, Focal segmental glomerulosclerosis |
NUP85 encodes nucleoporin 85 (656 aa). Essential component of the nuclear pore complex (NPC) that seems to be required for NPC assembly and maintenance. Highest expression in Brain Cerebellar Hemisphere (55.5 TPM) and Brain Cerebellum (51.1 TPM).
Nephrotic syndrome, type 17 is associated with mutations in the NUP85 gene on chromosome 17.
NUP85 is classified as a druggable target (Kinase category) with score 0.0.
Genetic testing for NUP85 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for nephrotic syndrome, type 17 has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 1 common feature.
No clinical trials have been registered for nephrotic syndrome, type 17.
3 publications have been identified in PubMed for nephrotic syndrome, type 17. Research spans Diagnostic / Biomarker (33%), Review / Meta-Analysis (33%), and Case Report / Case Series (33%).
Liu Y (2025). [PMID: 39834623](https://pubmed.ncbi.nlm.nih.gov/39834623/). *Clinical kidney journal*. [Case Report / Case Series]
Gajardo M (2025). [PMID: 40337643](https://pubmed.ncbi.nlm.nih.gov/40337643/). *Frontiers in molecular biosciences*. [Review / Meta-Analysis]
Ichikawa Y (2024). [PMID: 39093455](https://pubmed.ncbi.nlm.nih.gov/39093455/). *Pediatric nephrology (Berlin, Germany)*. [Diagnostic / Biomarker]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 5:19 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Growth and development |
1 |
Short stature |